HARVARD BIOSCIENCE, INC. Retained Earnings
HARVARD BIOSCIENCE, INC. (HBIO) had Retained Earnings of -$221.04 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$221.04M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$218.13M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$214.71M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$211.86M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$221.04M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$218.13M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$214.71M 10-Q · filed 2026-08-11 |
| 2025-09-30 | -$211.86M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$210.63M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$208.35M 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$158.01M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$158.03M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$153.23M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$150.30M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$145.60M 10-K · filed 2025-03-14 |
| 2023-09-30 | -$143.79M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$142.55M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$141.57M 10-Q · filed 2023-04-26 |
| 2022-12-31 | -$142.19M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$140.52M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$137.12M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$139.55M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$132.67M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$133.63M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$133.47M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$133.06M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$132.39M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$131.77M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$130.67M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$129.09M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$124.58M 10-K/A · filed 2021-03-17 |
| 2019-09-30 | -$125.13M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$122.51M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$122.26M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$119.89M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$122.75M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$122.50M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$121.03M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$116.97M 10-K · filed 2019-03-18 |
| 2017-09-30 | -$117.97M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$117.55M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$117.17M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$116.03M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$114.71M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$113.07M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$112.36M 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$111.72M 10-K · filed 2017-03-17 |
| 2015-09-30 | -$94.58M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$93.74M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$94.08M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$92.68M 10-K · filed 2016-04-29 |
| 2014-09-30 | -$92.67M 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$93.30M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$94.32M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$95.04M 10-K · filed 2015-03-12 |
| 2013-09-30 | -$78.33M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$77.35M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$77.16M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$77.26M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$78.46M 10-Q · filed 2012-11-08 |
| 2012-06-30 | -$78.33M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$79.10M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$79.63M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$80.37M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$80.40M 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$83.44M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |